The global Renal Cyst Treatment Market is poised for significant expansion, growing from an estimated USD 203.2 million in ...
The presence and number of kidney cysts, particularly in the medulla, may be an additional imaging-based biomarker for progressive CKD after radical nephrectomy for kidney cancer. Among patients who ...
Autosomal dominant polycystic kidney disease (PKD) is a chronic and debilitating condition affecting over 12 million patients worldwide. PKD arises from mutations in the polycystin-1 (PC1) or PC2 ...
Sanofi SNY announced that a pivotal phase II/III study — STAGED-PKD — evaluating its pipeline candidate, venglustat, in patients with autosomal dominant polycystic kidney disease (ADPKD) failed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback